Bibliographic information
GuidelineConsolidated guideline on sexual and reproductive health and rights of women living with HIV
Year of Publication2017
Issuing InstitutionWHO
Recommendation
New
Women using the newer non-nucleoside/nucleotide reverse transcriptase inhibitors (NNRTIs), etravirine and rilpivirine, can use all hormonal contraceptive methods without restriction (MEC Category 1) (Part I, section 12d).
Recommended in favor
Conditional
Certainty of evidence
Very low